Search Results For :: non-destructive testing
-
Non-Destructive Testing (NDT) Market by Component (Equipment, Services) Method (Ultrasonic, Radiography, Liquid Penetrant, Magnetic) End-User (Oil & Gas, Aerospace & Defense, Automotive, Infra) Technique, Application & Region - Global Forecast to 2022
The non-destructive testing (NDT) market is estimated to be USD 15.06 Billion in 2016 and is projected to reach USD 24.23 Billion by 2022, at a CAGR of 8.24% from 2016 to 2022. The market is evolving with the increased demand for error-free production and service delivery in industries, such as infrastructure, automotive, aerospace & defense, industrial manufacturing, power generation, and oil & gas, among others. Strict safety regulations formulated by governments, the need to preserve aging infrastructure, and development of advanced automated non-destructive testing equipment are additional factors driving the growth of this market.
- Published: January 2017
- Price: $ 4950
- TOC Available:
-
Acoustic Microscopy Market by Offering (Microscopes, Accessories & Software, Services), Application (Non-Destructive Testing, Quality Control, Failure Analysis), Industry (Semiconductor, Life Science), and Geography - Global Forecast to 2034
Factors driving the growth of the acoustic microscopy market includes safety regulations formulated by governments and international bodies, growth of various end-use industries, and increased funding for R&D in microscopy. Leading players operating in the acoustic microscopy market includes Sonoscan (US), Hitachi (Japan), PVA TePla (Germany), EAG Laboratories (US), NTS (US), Sonix (US), IP-holding (Germany), Insight K.K. (Japan), OKOS (US), MuAnalysis (Canada), Crest (Malaysia), Predictive Image (France), PicoTech (Israel), Acoustech Systems (US), and Accurex (India).
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Non-Destructive Testing (NDT) Market by Component (Equipment, Services) Method (Ultrasonic, Radiography, Liquid Penetrant, Magnetic) End-User (Oil & Gas, Aerospace & Defense, Automotive, Infra) Technique, Application & Region - Global Forecast to 2022
The non-destructive testing (NDT) market is estimated to be USD 15.06 Billion in 2016 and is projected to reach USD 24.23 Billion by 2022, at a CAGR of 8.24% from 2016 to 2022. The market is evolving with the increased demand for error-free production and service delivery in industries, such as infrastructure, automotive, aerospace & defense, industrial manufacturing, power generation, and oil & gas, among others. Strict safety regulations formulated by governments, the need to preserve aging infrastructure, and development of advanced automated non-destructive testing equipment are additional factors driving the growth of this market.
- Published: January 2017
- Price: $ 4950
- TOC Available:
-
Composites Testing Market by Testing Type (Destructive, Non-Destructive), Product Type (Continuous Fiber, Discontinuous Fiber, Polymer Matrix, Ceramic Matrix), Application (Aerospace & Defense, Transportation, Wind) & Region - Global Forecast to 2026
The composites testing market was valued at USD 1.47 Billion in 2015, and is projected to reach USD 3.06 Billion in 2026 at a CAGR of 6.95%. The use of composites is becoming crucial in the interior and exterior structural applications of aircraft and transport vehicles due their high strength, and superior performance. These composites have to comply with the stringent composites testing standards and manufacturers’ proprietary testing standards to ensure safety and durability.
- Published: November 2016
- Price: $ 4950
- TOC Available:
-
Non-Anticoagulant Rodenticides Market by Type (Bromethalin, Cholecalciferol, Strychnine, and Zinc Phosphide), Mode of Application (Pellets, Spray, and Powder), End Use (Agriculture, Warehouses, Urban Centers), Rodent Type, and Region - Global Forecast to 2030
The non-anticoagulant rodenticides market is forecasted to reach USD 1.43 billion by 2030, up from USD 1.11 billion in 2025, growing at a CAGR of 5.2% from 2025 to 2030. The report profiles key players such as BASF (Germany), Sumitomo Chemical (Japan), UPL Ltd (India), Bell Laboratories, Inc. (US), PCT Rural (Australia), Animal Control Technologies (Australia), Imtrade CropScience (Australia), Rentokil Initial plc (UK), AG Schilling & Co (Germany), 4Farmers Australia (Australia), Farmalynx Pty Ltd (Australia), Zagro (Malaysia), JT Eaton & Co., Inc. (USA), Neogen Technologies (USA), and Liphatech, Inc. (US). These companies are actively engaged in manufacturing and supplying zinc phosphide, bromethalin, cholecalciferol, and other non-anticoagulant rodenticides across agricultural, urban, and industrial sectors globally.
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
Preimplantation Genetic Testing Market by Product & Service (Reagents, Consumables, Instruments, Software), Technology (NGS, PCR, SNP, CGH), Procedure (Screening, Diagnosis), Application (Aneuploidy, HLA Typing), Type of cycle - Global Forecast to 2030
The global preimplantation genetic testing market, valued at US$636.4 million in 2024, stood at US$690.2 million in 2025 and is projected to advance at a resilient CAGR of 10.5% from 2024 to 2030, culminating in a forecasted valuation of US$1,135.0 million by the end of the period.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
NDT and Inspection Market by Technique (Ultrasonic Testing, Visual, Magnetic Particle, Liquid Penetration, Eddy-Current, Radiographic, Acoustic Emission), Service, Method, Vertical, Application and Region - Global Forecast to 2030
The NDT and inspection market is expected to grow from USD 11.6 billion in 2024 to USD 18.4 billion by 2029, at a compound annual growth rate (CAGR) of 9.6% during the forecast period.The key players General Electric (US), MISTRAS Group (US), Olympus Corporation (Japan), Ashtead Technology (Scotland), Nikon Metrology NV (UK), SGS Société Générale De Surveillance SA, (Switzerland), Magnaflux (US), Eddyfi Technologies (Canada), Sonatest (UK), Intertek Group plc (UK), Applus+ (Spain), Bureau Veritas (France), Comet Group (Switzerland), TUV Rheinland (Germany), FISCHER TECHNOLOGY INC. (US), Acuren (US), CREAFORM (Canada), Vidisco Ltd. (Israel), DEKRA (Germany), Team, Inc. (US), Labquip NDT (US), Cygnus Instruments Ltd. (UK), FPrimeC Solutions Inc. (Canada), Carestream Health (US), and Element Materials Technology (UK).
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Testing, Inspection, and Certification (TIC) Market by Service Type (Testing, Inspection, Certification), Source (In-house, Outsourced), Application (Consumer Goods & Retail, Agriculture & Food, Chemical, Energy & Power) - Global Forecast to 2030
The global testing, inspection, and certification (TIC) market is expected to grow from USD 239.48 billion in 2025 to USD 282.76 billion by 2030, at a compound annual growth rate (CAGR) of 3.4% during the forecast period. The Key Players SGS SA (Switzerland), Bureau Veritas (France), Intertek Group plc (UK), TÜV SÜD (Germany), and TÜV Rheinland (Germany).
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
Sugar Substitutes Market by Type (HFCS, High-intensity Sweeteners, Low-Intensity Sweeteners), Manufacturing Technology (Precision Fermentation, Enzymatic Conversion, Chemical Synthesis), Application, Form, Source, Region - Global Forecast to 2029
The sugar substitutes market is projected to reach USD 29.90 billion by 2029, at a CAGR of 4.9% during the forecast period. The report profiles key players such as Cargill, Incorporated (US), ADM (US), Ingredion (US), International Flavors & Fragrances Inc (US), Tate & Lyle (UK), Ajinomoto Co. Inc (Japan), GLG Life Tech Corp (Canada), Celanese Corporation (US), Roquette Frères (France), PCIPL (India), Mane SA. (France), Döhler GmbH (Germany), Morita Kagaku Kogyo Co., Ltd (Japan), zuChem (US), and Van Wankum Ingredients (Netherlands).
- Published: October 2024
- Price: $ 4950
- TOC Available:
-
Autologous Stem Cell & Non-stem Cell Therapies Market by Type (CAR-T, Tumor Infiltrating Lymphocyte), Indication (Cancer, Musculoskeletal, Dermatology), Source (T-Cells, Mesenchymal Stem Cell), End User (Hospital) & Region - Global Forecast to 2029
The global autologous stem cell & non-stem cell therapies market, valued at US$3.9 billion in 2023, stood at US$5.5 billion in 2024 and is projected to advance at a resilient CAGR of 32.3% from 2024 to 2029, culminating in a forecasted valuation of US$22.2 billion by the end of the period. The major factors driving the growth of this market are the rising regulatory approvals for autologous CAR T cell therapies, increasing R&D investments in autologous therapeutics, and growing demand for personalized medicines.
- Published: June 2024
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 63
